PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery Carrier for ovarian cancer therapy
Authors:
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 503 (3) , 1716-1722
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health and Welfare (1520100)
- Korea Institute of Science and Technology (2E27940)
This publication has 21 references indexed in Scilit:
- Heavy Chain Ferritin siRNA Delivered by Cationic Liposomes Increases Sensitivity of Cancer Cells to Chemotherapeutic AgentsCancer Research, 2011
- Transfection efficiency and intracellular fate of polycation liposomes combined with protamineBiomaterials, 2011
- Statistical Inference for Tumor Growth Inhibition T/C RatioJournal of Biopharmaceutical Statistics, 2010
- Efficient Liposomal Nanocarrier‐mediated Oligodeoxynucleotide Delivery Involving Dual Use of a Cell‐Penetrating Peptide as a Packaging and Intracellular Delivery AgentMacromolecular Rapid Communications, 2010
- DC-Chol/DOPE cationic liposomes: A comparative study of the influence factors on plasmid pDNA and siRNA gene deliveryInternational Journal of Pharmaceutics, 2010
- siRNA delivery systems for cancer treatmentAdvanced Drug Delivery Reviews, 2009
- Cationic liposome (DC-Chol/DOPE = 1:2) and a modified ethanol injection method to prepare liposomes, increased gene expressionInternational Journal of Pharmaceutics, 2007
- Antitumor Activity of a Kinesin InhibitorCancer Research, 2004
- Safety and Toxicity of Catheter Gene Delivery to the Pulmonary Vasculature in a Patient with Metastatic MelanomaHuman Gene Therapy, 1994
- Neurotoxicity secondary to antineoplastic drugsCancer Treatment Reviews, 1994